Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001865125-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 7, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
476,385
Total Value
$11,282,553.82
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 4, 2026 | Exercise/Conversion | 87,373 | $2.48 | $216,685.04 | 87,373 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 4, 2026 | Exercise/Conversion | 27,567 | $25.28 | $696,893.76 | 114,940 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 4, 2026 | Exercise/Conversion | 23,364 | $14.85 | $346,955.40 | 138,304 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 4, 2026 | Exercise/Conversion | 20,491 | $22.47 | $460,432.77 | 158,795 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 4, 2026 | Sale | 158,795 | $60.21 | $9,561,586.85 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Aug 4, 2026 | Exercise/Conversion | 87,373 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Aug 4, 2026 | Exercise/Conversion | 27,567 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Aug 4, 2026 | Exercise/Conversion | 23,364 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Aug 4, 2026 | Exercise/Conversion | 20,491 | $0.00 | $0.00 | 0 | Direct | โ | View Details |